Grace Therapeutics Inc (GRCE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2016 | 02-2016 | 12-2015 | 11-2015 | 09-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,840 | N/A | -3,330 | -3,330 | -1,720 |
| Depreciation Amortization | 1,830 | N/A | 1,350 | 1,350 | 8 |
| Accounts receivable | N/A | 36 | N/A | 0 | N/A |
| Accounts payable and accrued liabilities | N/A | 38 | N/A | 0 | N/A |
| Other Working Capital | -30 | N/A | 390 | 390 | 120 |
| Other Operating Activity | -2,000 | -75 | -2,100 | -2,100 | -948 |
| Operating Cash Flow | $-5,040 | $N/A | $-3,690 | $-3,690 | $-2,540 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 6,508 | N/A | 0 | N/A |
| PPE Investments | -210 | N/A | -160 | -160 | -100 |
| Purchase Sale Intangibles | N/A | -70 | N/A | 0 | N/A |
| Other Investing Activity | 6,520 | -6,508 | 6,400 | 6,400 | 3,610 |
| Investing Cash Flow | $6,310 | $N/A | $6,240 | $6,240 | $3,510 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 1 | N/A | 0 | N/A |
| Other Financing Activity | -2 | -1 | -2 | -2 | -1 |
| Financing Cash Flow | $-2 | $N/A | $-2 | $-2 | $-1 |
| Exchange Rate Effect | 40 | N/A | 6 | 6 | 40 |
| Beginning Cash Position | 1,000 | N/A | 990 | 990 | 1,020 |
| End Cash Position | 2,320 | N/A | 3,590 | 3,590 | 2,030 |
| Net Cash Flow | $1,310 | $N/A | $2,600 | $2,600 | $1,010 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,040 | N/A | -3,690 | -3,690 | -2,540 |
| Capital Expenditure | N/A | -212 | N/A | 0 | N/A |
| Free Cash Flow | -5,040 | -212 | -3,690 | -3,690 | -2,540 |